Table 3.2: Overall survival (OS) and cumulative mortality rates (CMR) for both competing risks concerning therapy group EBRT.

Years

OS

CMR tumor specific (95%CI)

CMR Comorbidity specific (95%CI)

2

97.7

0.6 (0.0 - 1.4)

1.7 (0.50 - 2.8)

4

94.6

1.6 (0.4 - 2.7)

3.8 (2.0 - 5.6)

6

92.2

2.1 (0.7 - 3.5)

5.7 (3.5 - 8.0)

8

88.2

3.4 (1.5 - 5.2)

8.4 (5.6 - 11.3)

10

84.3

4.2 (2.0 - 6.3)

11.6 (8.0 - 15.2)

12

81.1

6.0 (3.1 - 9.0)

12.8 (8.9 - 16.8)

14

76.1

9.3 (5.0 - 13.5)

14.6 (10.0 - 19.2)

16

69.0

11.4 (6.3 - 16.4)

19.6 (13.5 - 25.7)

18

61.7

13.7 (7.0 - 20.5)

24.6 (16.6 - 32.5)

20

56.8

16.2 (8.1 - 24.4)

27.1 (18.0 - 36.1)